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Abstract
It is well known that the protective capacity of the collateral circulation falls short in many
individuals with ischemic disease of the heart, brain and lower extremities. In the past fifteen
years, opportunities created by molecular and genetic tools, together with disappointing outcomes
in many “angiogenic” trials, has led to a significant increase in the number of studies that focus
on: 1) understanding the basic biology of the collateral circulation; 2) identifying the mechanisms
that limit the collateral circulation’s capacity in many individuals; 3) devising methods to measure
collateral extent, which has been found to vary widely among individuals; and 4) developing
treatments to increase collateral blood flow in obstructive disease. Unfortunately, accompanying
this increase in reports has been a proliferation of vague terms used to describe the disposition and
behavior of this unique circulation, as well as the increasing miss-use of well-ensconced ones by
new (and old) students of the collateral circulation. With this in mind, we provide a brief glossary
of readily understandable terms to denote the formation, adaptive growth, and mal-adaptive
rarefaction of the collateral circulation. We also propose terminology for several newly discovered
processes that occur in the collateral circulation. Finally, we include terms used to describe vessels
that are sometimes confused with collaterals, as well as terms describing processes active in the
general arterial-venous circulation when ischemic conditions engage the collateral circulation. We
hope this brief review will help unify the terminology used in collateral research.
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The collateral circulation is a network of specialized “endogenous bypass vessels” that is
present in most tissues and provides protection against ischemic injury caused by ischemic
stroke, coronary atherosclerosis, peripheral artery disease and other conditions and diseases.
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Unfortunately, this protection falls far short in a large fraction of individuals due to
differences in the number or diameter of these vessels present before—and/or their ability to
undergo adaptive growth after—the onset of occlusive disease. Not surprising then, are the
increasing number of reports in the literature that focus on: 1) understanding the basic
biology of the collateral circulation; 2) identifying the genetic, cellular and environmental
mechanisms that limit the collateral circulation’s capacity in many individuals to provide
alternative routes of flow; 3) devising methods to measure collateral extent, which varies
widely among individuals; and 4) developing treatments to increase collateral blood flow in
obstructive disease. Indeed, it is becoming evident that collaterals differ so much from
arteries, capillaries and veins in phenotypic and functional properties that they might well be
considered a “third circulation” along with the general arterial-venous and lymphatic
circulations. However, much less is known about the collateral circulation.
Accompanying the increased number of papers studying the collateral circulation in tissues
is a mushroom-like proliferation of vague terms used to describe the disposition and
behavior of these peculiar vessels. Webster’s Dictionary defines collateral as “coinciding in
tendency or effect.” Accordingly, a collateral vessel would be one capable of supplying flow
to an area normally supplied by another vessel, ie, coinciding in effect. However, the term
has other common meanings, as shown by the many miss-hits returned by a Pubmed or
Google search on “collateral”, when the searcher’s interest is the collateral circulation,
rather than arteriovenous shunts, recurrent nerves, ligaments, roadways or real estate
purchases. Moreover, in addition to the proliferation of ambiguous terms is the increasing
miss-use of well-ensconced ones by new (and old!) students of the collateral circulation.
To help “collaterologists” better communicate with each other and with the outsider looking
in, we offer here a brief glossary of, hopefully, readily understandable terms that are often
used to denote the formation, adaptive growth, and mal-adaptive rarefaction of the collateral
circulation. We also include terms used to describe vessels that are sometimes confused with
collaterals, or processes active in the general arterial-venous circulation that accompany
ischemic conditions that engage the collateral circulation. We hope this modest attempt at
unifying the terminology used in study of the collateral circulation encourages practitioners
to send us feedback and additional terms that we may have missed. Where needed, a term
and its definition is followed in brackets by terms, both old and new, that have been used to
mean the same thing but are either less clear and we suggest better avoided or used with
caution, or are/have been used in other areas of vascular research to mean something
different thus creating an opportunity for confusion. Lastly, given the availability of many
reviews addressing the collateral circulation and the general vascular terms discussed below,
as well as the nature and limited-space format of this commentary, we provide a limited
number of representative references when the issue at hand is less widely known, not
addressed in the reviews, or has only recently been described.
Collaterals — naturally occurring artery-to-artery or arteriole-to-arteriole anastomoses
present in healthy tissues that increase their anatomic diameter, ie, outwardly remodel, in
obstructive disease (Figure). Because they cross-connect two feed-arteries or the crowns of
adjacent arterial trees, respectively, blood flow along their length comes from opposite
directions in the healthy tissue at baseline.1–3 This results in a “to and fro” flow that
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prevents hemostatic thrombosis, resulting in little or no net-flow at a point generally near the
midpoint of the collateral. Thus, collaterals reside in a unique hemodynamic environment of
low and oscillatory shear stress. Collaterals should not be confused with arteriovenous
anastomoses (shunt vessels) which have long been called collaterals in some clinical areas
(eg, lung4). Two types of collaterals are distinguished:
Collateral arteries — artery-to-artery anastomoses that tend to be present in similar
locations among humans and other mammalian species. Usually carry explicit
names in human, eg: superior ulnar collateral artery, genicular artery and other
anastomotic arteries around elbows, knees and other articulations, palmar and
plantar arch collaterals, ileolumbar-superior epigastric communicating artery,
bronchial-to-pulmonary vein arteries, other collateral arteries in the abdomen and
thorax, anterior and posterior communicating arteries/collaterals of the circle of
Willis. Compared to microvascular collaterals (defined below), collateral arteries in
healthy young adults generally exhibit minimal or no tortuosity, undergo
considerably less anatomic lumen enlargement on a percentage basis
(“remodeling”) in response to a chronic increase in shear stress in obstructive
disease,5,6 form during embryogenesis by a different process (discussed below).
Microvascular collaterals — arteriole-to-arteriole anastomoses that cross-connect a
small fraction (generally < 0.05%) of the arterioles in the crowns of adjacent
arterial trees. Average less than 100 microns diameter in most healthy species
including human (Figure). Present in most but not all tissues (eg, absent in the
retinal circulation and non-capsular kidney except in rare circumstances7).
Examples: pial (leptomenigeal) collaterals of the brain and spinal cord, coronary
collaterals, collaterals in skeletal muscle and skin. Depending on species and tissue,
several collaterals may have artery-size calibers (greater than ~150 µm, the
diameter generally used to distinguish arterioles from arteries8) eg, in the healthy
heart9–11 and between the crowns of the superior and inferior epigastric and other
thoraco-abdominal artery trees. Characteristics of microvascular collaterals:
significant tortuosity even in young adults, outward remodeling of their lumen
diameters generally by 5-to-10-fold in humans with occlusive disease,10–12 and at
least in mouse strains, large genetic background-dependent variability in their
number, diameter and remodeling.2,13 Since many collateral arteries carry explicit
names (eg, as given above), use of the term “collaterals”, alone, will usually imply
the population of microvascular collaterals in a given tissue.
Collateral arteries and microvascular collaterals usually have one or more side-branches.
Thus, besides presumably helping to optimize regional metabolic control of oxygen delivery
in healthy tissues, collaterals also serve as scaffolds for delivery of blood flow to
parenchymal tissue within the “collateral zone” (watershed) between adjacent artery trees.13
The above collateral vessels are further distinguished from other types of arterial
anastomoses that are collateral-like but are not denoted as collaterals, per se. There are two
types:
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Intra-tree anastomoses — arteriole-to-arteriole anastomoses that, where present,
connect adjacent branches within a given tree. Present in many tissues, eg, in
heart,9 skeletal muscle,14,15 intestinal mesentery,8 and the cerebral cortex of many
species (eg, rat16 but not mouse2). Like collaterals, they can have opposing flow at
their mid-point.8 They also serve the same “endogenous bypass function” of
collaterals if an adjacent branch becomes obstructed.17 However, since they protect
much less tissue, do not interconnect separate arterial trees, are much shorter and
have little or no tortuosity, they are denoted with a unique term.
Arcade arteries — arteries that often take an arching course and may or may not,
depending on the individual, anastomose with another artery, for example in
human: gastric and omental arcade arteries, marginal mesenteric arteries,
pancreaticoduodenal arcade, gastroepiploic artery, internal thoracic artery,
collateral intercostal artery, vasa vasorum of the aorta, and arteries supplying long
axial structures (eg, bile duct, trachea, spinal cord).18
Native collaterals — collateral arteries and microvascular collaterals that are present in
healthy tissues, ie, free of arterial obstruction (Figure). A healthy tissue at rest has little or no
pressure drop across its collaterals, thus little or no net collateral flow between the
interconnected trees.2–3 This causes even high resolution flow-based imaging methods (eg,
laser speckle contrast) to be “blind” to the presence of native collaterals until obstruction is
induced.19 Also, microvascular collaterals in healthy tissues are generally below the
resolution of conventional in vivo angiographic methods. Thus, the functional importance of
native collaterals in many tissues was doubted for many years.10,11 However, improvements
in vascular casting and other anatomic techniques (eg, 3D reconstruction with micro-CT or
cryomicrotome9), Doppler and other flow-based imaging methods, and indirect methods of
measuring collateral-dependent flow,20,21 allow detection in experimental animals and
patients, although limits to resolution for non-casting methods do not allow quantification of
collateral extent below certain diameters. [Synonym: pre-existing collaterals].
Collateral extent — collective term to denote the combination of number and average
diameter of native, pre-existing collaterals in a tissue without obstructed flow. Collateral
extent varies widely among and within the same species—at least in the case of mice—
primarily due to variation at a single genetic locus.23 It has also been suggested to vary
widely in the coronary circulation of healthy pound dogs, based on a 10-fold variation in
wedge pressure measured from the circumflex artery.22 And likewise in patients with acute
stroke20 or without coronary artery disease,21 where differences in collateral remodeling (ie,
arteriogenesis, defined below) secondary to chronic arterial obstruction are not present to
confound the interpretation vis-à-vis native collateral extent. “Environmental” factors such
as aging and chronic endothelial dysfunction have been shown to reduce collateral extent in
mice.24 [Avoid: collateralization.]
Collateral recruitment — induction of flow from an adjacent arterial tree(s) to the obstructed
tree across a collateral(s) (Figure). Caused by sudden or chronic obstruction, which creates a
pressure drop across the collateral network. [Avoid: active/patent/open collaterals, since
native collaterals have not been observed to reside in a constricted, closed state.]
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Arteriogenesis — anatomic increase in lumen area and wall thickness of a collateral vessel.
Induced by a shear stress-mediated process10–12 and in certain tissues from factors released
in the ischemic environment.25 Induced by periodic or sustained, or partial or complete,
obstruction of flow in one of the adjacent arterial trees, which causes unidirectional flow
across the collateral(s). Requires days-to-weeks for the final new diameter to be achieved,
depending on tissue, species and amount of remodeling. Usually accompanied by an
increase in collateral length, resulting in increased tortuosity. Synonym: collateral
remodeling (Figure). [Avoid collateral: -dilation, since dilation denotes a sudden increase in
vessel diameter due to relaxation of smooth muscle; -dilatation or -expansion, since these
terms are variably used to mean either anatomic lumen enlargement or dilation; -
development or -formation, since these terms are also used to denote de-novo vessel
formation in the embryo or after birth; -growth, since this is often used as a synonym for
arteriogenesis but does not distinguish it from formation of new collaterals (see
“collaterogenesis”, below). Avoid: collateralization.]
Of note, the term arteriogenesis with its above definition was introduced nearly two decades
ago26 and since then has been used in the majority of papers studying the collateral
circulation to denote the above process. However, the term has also acquired several
different meanings: 1) Arteriogenesis was used in several earlier reports to describe the
outgrowth of surrounding arterioles into prolactinomas in the anterior pituitary27 and into
surgically placed plastic meshes.28 2) It is also used in developmental biology to indicate the
formation of artery trees in the embryo by remodeling of the primary embryonic capillary
plexus (termed “tree formation” or “arterial morphogenesis”, discussed below). 3)
Furthermore, arteriogenesis has been used to denote an increase in the size (territory) of an
arterial tree during post-natal tissue growth or due to other conditions or experimental
interventions29 (termed “tree growth”, discussed below).
Other notes: Arteriogenesis has often been used to denote the remodeling of native
microvascular collateral arterioles into arteries, sometimes accompanied by the statement
that the former have little or no importance until they remodel into “functional arteries”.
However, it is becoming more widely appreciated that, depending on their extent, native
microvascular collaterals can provide significant functional flow that substantially lessens
ischemic tissue injury after sudden arterial obstruction before they remodel.13,22–24,30
Improved (or impaired) arteriogenesis/collateral remodeling is often invoked as the sole
mechanism underlying an experimental intervention that results in an increase (or decrease)
in recovery of blood flow to a tissue over time after arterial obstruction, even though other
mechanisms may be involved (albeit generally with less impact) that are capable of causing
or contributing to this, eg, angiogenesis (increased capillary number), or changes in pressure
and resistance above or below the collateral network—the latter from vasoactive, edematous
or leukocyte-platelet adhesive mechanisms.
Collateral regression — the process of reverse-remodeling that occurs after removal of an
obstruction (eg, after stenting),31 or in the setting of sudden obstruction wherein several
native collaterals sometimes remodel more and thus become “dominant” over others that
regress back toward their native diameters.30,32 If the aforementioned scenarios lead to loss
of collaterals that were formerly present, rather than regression below threshold for
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detection, this would constitute collateral regression (see below), although such has not been
described in the literature.
Collateral rarefaction — loss of native collateral number and/or a decrease in collateral
diameter from that present in the healthy adult (Figure). Studies in mice have found that a
decrease in the number and diameter of microvascular collaterals occurs with aging,
endothelial dysfunction, and the presence of certain other cardiovascular risk factors and
diseases24—findings supported by recent studies in humans.33,34 [Avoid “pruning” in this
context since it is better used to denote the process during normal development of removal
of a portion of the branches from a nascent capillary plexus, eg, in the developing retinal
vasculature35 and the removal during the first few weeks after birth of a fraction of the
nascent arteriole anastomoses that form during collaterogenesis in the mouse embryo.2]
Collaterogenesis — formation of collaterals during embryonic and postnatal development to
yield the collateral extent present in the healthy adult tissue. There are two types:
Arterial collaterogenesis: Based mostly on studies of the origin of the collateral
arteries of the circle of Willis where it has been studied in detail,eg, 36 arterial
collaterals present in the adult may arise by either retension of a vessel(s) present
early in embryonic development (embryonic remnant) or by a different collateral
connection that replaces the early vessel later in development. This results in the
variable presence, diameter and location of arterial collaterals among adults (eg,
presence in the adult of the “embryonic” (remnant) versus “adult” morphology/
pattern of the posterior communicating collateral arteries of the circle of Willis).
Microvascular collaterogenesis: Based on studies in mouse brain were the process
can be studied with fidelity, collaterals form during gestation relatively late, after
the arterial trees have formed (Figure).2,37 The nascent collaterals then become
invested with smooth muscle cells, increase their diameter, and reduce their number
by a pruning process. This process of maturation of the collateral circulation is
completed during the first several weeks after birth, resulting in the collateral
number and diameter present in the adult. Coronary collaterogenesis in humans
also occurs relatively late (19-39 weeks of gestation),38 after coronary artery tree
formation (weeks 8-16).10
Neo-collateral formation — de novo formation of additional or “new” microvascular
collaterals after arterial obstruction in the adult (Figure). Whether this occurs has long been
debated,10,11 since previous studies were unable to exclude the possibility that newly
detected collaterals in the setting of arterial obstruction were native collaterals that had
escaped detection until they had remodeled. However, neo-collateral formation has recently
been reported after acute arterial occlusion in murine brain13 and skeletal muscle.39
Supporting the concept that neo-collaterals can form in humans is the well-known detection
of an apparent profusion of ectopic microvascular collaterals in patients with moyamoya
syndrome,40 the salutory effect of the encephaloduro-arteriosynangiosis surgical procedure
used in certain types of cerebral artery occlusion not amenable to thrombolysis or
thrombectomy41 and the Vineberg procedure that antedated coronary artery bypass
grafting.42
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The following are terms describing processes often active in the general arterial-venous
circulation when ischemic conditions engage the collateral circulation. They are also
sometimes used to include or even denote collateral remodeling/arteriogenesis or
neocollateral formation, which can result in confusion.
Arterialization — increase in number and/or length of the distal-most arterioles of an arterial
tree, ie, an increase in territory of an artery tree in the adult. Caused by chronic exercise or
muscle loading,43 chronic dilation-induced increase in wall stress within a tree,44,45 and in
certain experimental settings showing that arterialization depends on a distinct signaling
cascade.46 Evidence supports involvement of muralization by smooth muscle cells of pre-
existing and/or newly formed capillaries, followed by lumen enlargement and wall
thickening, a process that has also been associated with neo-collateral formation.39 A related
process, distal muscularization, occurs in pulmonary hypertension, where small precapillary
arterioles that normally lack smooth muscle cells become invested with smooth muscle
actin-expressing cells.47 Note, arterialization is also used to denote the changes in thickness
of a donor vein after arterial bypass grafting or pathological conditions such as in the portal
vein in acute liver failure.
Tree growth — the process during gestation, postnatal tissue growth, vascular hypertrophy
or other conditions, of an increase in anatomic territory of an artery or vein tree. Often
quantified as an increase in the diameter of its trunk and branches, branch number, branch
length, number of branching orders, and number of branches each order has. Synonym:
arterialization when referring to arterial trees in the adult.
Angiogenesis — formation of capillaries from pre-existing capillaries. Two variations are
distinguished, based on time of occurrence:
Embryonic angiogenesis — formation of additional capillaries in the embryonic
plexus and certain elongated capillary vessels (eg, intersomitic vessels sprouting
from the dorsal aortae) due to sprouting from existing capillaries and
intussusception of pre-existing capillaries. [Confusion may arise with use of the
term, angiogenesis, to include the subsequent embryonic remodeling of the plexus
into artery and vein trees—a process that is also denoted arterial and venous
morphogenesis.]
Postnatal/adult angiogenesis —increase in capillary number or length caused by
sprouting or intussusception that occurs in a tissue during growth to adulthood,
adaptive hypertrophy, or changes in metabolism (eg, skeletal muscle fiber type
switching). Also accompanies repair and pathological processes (eg, tissue injury,
ischemia, inflammation, tumor growth). In certain tissues the capillary plexus
forms after birth and then undergoes remodeling into artery and vein trees (eg,
mouse retina).
Importantly, the term angiogenesis is sometimes used as a general term to denote the de
novo formation or increase in diameter, length or branching of any type of vessel in any type
of physiological, pathological or therapeutic setting during gestation and thereafter.
However, this general use of the term is subject to confusion.
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Therapeutic angiogenesis — general term used to denote a pharmacologic (or other
therapeutic) stimulation of “vessel growth” or new vessel formation, resulting in an increase
in tissue blood flow at baseline or at maximal dilation after acute or chronic arterial
obstruction. It is attributable to one or more of the following in response to a treatment
administered before or after onset of arterial obstruction: 1) increased number of capillaries
(angiogenesis), 2) remodeling of native collaterals, 3) neo-collateral formation, and 4)
arterialization. However, in addition to potential contributions of these mechanisms, such
increases in flow can also be caused by an increase in perfusion pressure or decrease in
resistance above or below a collateral network whose extent is unchanged. Given the above,
and since the term does not denote an underlying mechanism(s), its meaning can be
misapplied or misinterpreted if the context is not made clear. Thus far, no therapeutics that
augment angiogenesis or collateral remodeling in patients have been approved, although
several are under investigation. [Synonym: therapeutic revascularization, which usually
refers to abolishment or lessening of the deficiency of perfusion in obstructive conditions by
one or more of the above mechanisms. However, a number of different endovascular and
surgical arterial procedures are also termed revascularization.]
Neovascularization — a synonym for “therapeutic angiogenesis”. However, since it can also
mean physiological or pathological (eg, inflammatory) “vessel growth”, per the above
mechanisms, its use is subject to the same limitations as therapeutic angiogenesis.
[Synonym: neo-vessel formation]
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Major aspects of the vascular biology of the collateral circulation. Embryonic formation of
native collaterals (collaterogenesis), which is depicted in the upper right diagram as several
collaterals forming between two trees, begins at ~E14 in mouse and determines collateral
extent in the adult (center diagram with several collaterals shown connecting two arterial
trees).37 Acute obstruction induces flow across the collateral network (recruitment),
followed by remodeling and, potentially, formation of additional collaterals in chronic
obstructive disease (neo-collateral formation). Loss of native collaterals (rarefaction) can be
caused by aging and other risk factors. The two arterial trees in the center of figure are
modification of the logo for the Fifth International Angiogenesis Meeting, Amsterdam,
2014. The mouse embryo image (E14) is from: http://www.emouseatlas.org/emap/ema/
home.html.
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